32DThe Australian Medical Research and Innovation Strategy

32D The Australian Medical Research and Innovation Strategy

(1) The Advisory Board must determine a strategy for ensuring that a coherent and consistent approach is adopted in providing financial assistance under this Act for medical research and medical innovation. (2) The first Australian Medical Research and Innovation Strategy must be determined as soon as practicable after this section commences. A subsequent Strategy must be determined and in force as soon as the current Strategy ceases to be in force. (3) In determining the Australian Medical Research and Innovation Strategy, the Advisory Board must take into account: (a) the national strategy for medical research and public health research prepared for the purposes of paragraph 16(2)(c) of the National Health and Medical Research Council Act 1992; and (b) any other relevant matter.

Note: The Advisory Board is also required to provide a consultation process before determining the Strategy—see section 32EA.

(4) An Australian Medical Research and Innovation Strategy is in force for 5 years. (5) An Australian Medical Research and Innovation Strategy must not require financial assistance to be provided to a particular person, or for a particular project. (6) An Australian Medical Research and Innovation Strategy is a legislative instrument, but section 42 (disallowance) of the Legislation Act 2003 does not apply to the Strategy. (7) In addition to the requirement under the Legislation Act 2003 for an Australian Medical Research and Innovation Strategy to be registered, the Advisory Board must ensure that the Strategy that is in force is published on the internet. (8) Subsection 33(3) of the Acts Interpretation Act 1901 does not apply in relation to the power under this section to determine an Australian Medical Research and Innovation Strategy.